Valuation Pharmaids Pharmaceuticals Limited

Stocks

Market Closed - Bombay S.E. 06:22:22 2026-10-30 EDT			5-day change	1st Jan Change
27.72 ^INR	-2.46%		-2.01%	-41.84%

08-12	Pharmaids Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
05-29	Pharmaids Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026
Market Cap ¹	115.3	129	488.8	1,834	2,422	975.9
Change	-	11.9%	278.93%	275.2%	32.06%	-59.71%
Enterprise Value (EV) ¹	113.3	124.9	328.2	1,871	2,821	1,240
Change	-	10.28%	162.73%	470.15%	50.74%	-56.04%
P/E	124x	89.4x	-3.72x	-14.8x	-22.5x	-8.33x
PBR	1.35x	1.49x	2.09x	2.55x	4.08x	2.05x
PEG	-	1.6x	0x	0.4x	1.7x	-0.95x
Capitalization / Revenue	1.35x	3.27x	-	12.1x	12.5x	3.5x
EV / Revenue	1.32x	3.17x	-	12.4x	14.5x	4.45x
EV / EBITDA	106x	91.1x	-3.45x	-13.8x	-21.2x	-8.78x
EV / EBIT	182x	97.7x	-3.44x	-12.7x	-18.6x	-7.97x
EV / FCF	32x	37x	-4.61x	-6.08x	-14.9x	-8.87x
FCF Yield	3.13%	2.71%	-21.7%	-16.5%	-6.7%	-11.3%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	0.09	0.14	-5.86	-3.507	-3.056	-3.322
Distribution rate	-	-	-	-	-	-
Net sales ¹	85.51	39.39	-	151.1	194.5	278.8
EBITDA ¹	1.069	1.371	-95.2	-135.5	-132.8	-141.2
EBIT ¹	0.6209	1.279	-95.37	-146.9	-151.8	-155.6
Net income ¹	0.9331	1.451	-75.56	-79.68	-107.8	-117.2
Net Debt ¹	-2.003	-4.074	-160.6	37.29	398.8	264
Reference price ²	11.18	12.51	21.81	52.00	68.67	27.67
Nbr of stocks (in thousands)	10,311	10,311	22,411	35,268	35,268	35,268
Announcement Date	8/30/21	7/23/22	8/31/23	9/3/24	8/29/25	8/18/26

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
PHARMAIDS PHARMACEUTICALS LIMITED	-	-	-	-	10.53M
ELI LILLY AND COMPANY	40.35x	13.85x	30.26x	0.5%	1,224B
JOHNSON & JOHNSON	40.28x	6.76x	19.02x	1.94%	662B
ABBVIE INC.	38.08x	8.51x	17.61x	2.36%	514B
ROCHE HOLDING AG	21.65x	5.25x	13.07x	2.49%	388B
MERCK & CO., INC.	106.67x	5.95x	25.48x	2.33%	361B
NOVARTIS AG	22.86x	5.89x	14.22x	2.75%	302B
ASTRAZENECA PLC	22.82x	4.6x	13.15x	1.92%	271B
AMGEN INC.	29.23x	7.45x	13.34x	2.19%	249B
GILEAD SCIENCES, INC.	-47.64x	7.37x	28.55x	1.99%	205B
Average	30.48x	7.29x	19.41x	2.05%	417.69B
Weighted average by Cap.	36.66x	8.71x	21.55x	1.73%